NBT Bancorp Appoints Kimberly A. Boynton to Board; Board Size Rises to 13
$NBTB · NBT BANCORP INCResearch Summary
AI-generated summary of this SEC filing
NBT Bancorp Appoints Kimberly A. Boynton to Board; Board Size Rises to 13
What Happened
NBT Bancorp Inc. announced that on September 21, 2026 its Board increased the number of directors to thirteen and appointed Kimberly A. Boynton, age 57, to fill the new vacancy effective October 1, 2026. Ms. Boynton is a licensed real estate agent with Cushman & Wakefield | Pyramid Brokerage Company and previously served as President & CEO of Crouse Health (Jan 2014–Mar 2023) after earlier roles including CFO and experience in public accounting.
Key Details
- Appointment effective October 1, 2026; Board size increased to 13 directors.
- Ms. Boynton’s background: healthcare executive (former CEO/CFO of Crouse Health), commercial real estate, and public accounting experience.
- Board determined she meets Nasdaq independence standards; expected to serve on the Audit Committee, Compensation and Benefits Committee, and Risk Management Committee.
- No reportable related‑party transactions between Ms. Boynton (or immediate family) and NBT; she received no compensation for the appointment but will receive standard director compensation, including a prorated restricted stock unit grant and prorated retainers.
Why It Matters
This is a governance update that adds a director with executive leadership, financial management and regional commercial real estate experience—attributes the company says will enhance Board perspective on Central New York businesses and community needs. For investors, the change affects board composition and committee membership (Audit, Compensation, Risk), which can influence oversight of strategy, risk and executive pay. The filing contains no transactions or conflicts that would require related‑party disclosure.